Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy
NEJM 362:790-799, Glauser,T.A.,et al, 2010
Treatment of Absence Status with Intravenous Valproate
Neurol 52:889-890, Alehan,F.K.,et al, 1999
Non-Convulsive Status Epilepticus:Causes, Treatment, and Outcome in 65 Patients
JNNP 61:93-95, Scholtes,F.B.,et al, 1996
Lamotrigine for the Treatment of Epilepsy in Childhood
J Pediatr 127:991-997, Besag,F.M.C.,et al, 1995
'De Novo'Absence Status of Late Onset:Report of 11 Cases
Neurol 42:104-110, Thomas,P.,et al, 1992
Effect of Add-on Amantadine Therapy for Refractory Absence epilepsy
J Pediatr 121:819-821, Shahar,E.M.&Brand,N., 1992
Valproate Prevents the Recurrence of Absence Status
Neurol 39:1294-1297, Berkovic,S.F.,et al, 1989
Comparison of Monotherapy with Valproate and Other Antiepileptic Drugs in the Treatment of Seizure Disorders
Am J Med 84: (Supp1A) , 3-688., Chadwick,D., 1988
Epilepsies of Infancy & Childhood
Ann Neurol 13:113-124, Gomez,M.R.,et al, 1983
Valproate-Ethosuximide Combination Therapy for Refractory Absence Seizures
Arch Neurol 40:797-802, Rowan,A.J.,et al, 1983
Valproic Acid
NEJM 302:661-666, Brown,T.R., 1980
Valproic Acid Therapy in Childhood Epilepsy
JAMA 244:785-788, Coulter,D.L.,et al, 1980
Drug Therapy, Clonazepam
NEJM 299:812-816, Brown,T.R., 1978
Imipramine in Absence & Myoclonic-astatic Seizures
Neurol 28:953-957, Fromm,G.H.,et al, 1978
Sodium Valproate & Clonazepam in the Treatment of Intractable Epilepsy
Arch Neurol 34:14, Lance,W.,et al, 1977
Emergency Management of the Patient with Seizures
Postgrad Med 55:59, Conomy,J.,et al, 1974
Petit Mal:A Critique Review
Neurol 17:197, Hanotia,P., 1969
Long-Term Follow-up of Patients with Petit Mal
Arch Neurol 16:595, Charlton,M.H.,et al, 1967
Epilepsy in Children
Current Therapy, 1966, p. 574., Scholl,M.L., 1966
Petit Mal Epilepsy
JAMA 194:113, Livingston,S.,et al, 1965
A 62-Year-Old Woman with Bizarre Behavior and Recurrent Episodes of Behavioral Arrest
Neurol 86:e62-e65, Briglia, H.,et al, 2016
Febrile Infection-Related Epilepsy Syndrome: A Study of 12 Patients
Seizure 22:553-559, Caraballo, R.H.,et al, 2013
Status Epilepticus: A Review of Different Syndromes, Their Current Evaluation, and Treatment
The Neurologist 9:61-76, Gaitanis,J.N. &Drislane,F.W., 2003
Do Nonconvulsive Seizures Damage the Brain? Yes
Arch Neurol 55:117-120, Young,G.C.&Jordan,K.G., 1998
Do Nonconvulsive Seizures Damage the Brain? No
Arch Neurol 55:119-120, Aminoff,M.J., 1998
Seizures and Epilepsy in the Elderly
Arch Int Med 157:605-617, Thomas,R.J., 1997
Juvenile Myoclonic Epilepsy
Arch Neurol 50:594-598, Grunewald,R.A.&Panayiotopoulos,C.P., 1993
Clinical and EEG Features of Status Epilepticus in Comatose Patients
Neurol 42:100-104, Lowenstein,D.H.&Aminoff,M.J., 1992
Delayed Diagnosis of Juvenile Myoclonic Epilepsy
JNNP 55:497-499, Grunewald,R.A.,et al, 1992
Neonatal Seizures
NEJM 388:1692-1700, Ropper.A.H., 2023
Drug Resistant Epilepsy in a 61-Year-Old Man with Abnormal MRI Brain Findings and Management with Vagal Nerve Stimulator
Neurol 100:1111-1116, Mankad,J.P. & Lavingia,J.R., 2023
The SANAD II study of the Effectiveness and Cost-Effectiveness of Levetiracetam, Zonisamide, or Lamotrigine for Newly Diagnosed Focal Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1363-1374, Marson, A.,et al, 2021
The SANAD II Study of the Effectiveness and Cost-Effectiveness of Valproate Versus Levetiracetam for Newly Diagnosed Generalised and Unclassifiable Epilepsy: An Open-Label, Non-Inferiority, Multicentre, Phase 4, Randomised Controlled Trial
Lancet 397:1375-1386, Marson, A.,et al, 2021
Vagus Nerve Stimulation and Seizure Outcomes in Pediatric Refractory Epilepsy
Neurol 96:1041-1051, Jain, P. & Arya, R., 2021
Initial Management of Seizure in Adults
NEJM 385:251-263, Smith, P.E.M., 2021
Clinicopathologic Conference, Seizure from Neurocysticercosis
NEJM 385:1894-1902, Case 34-2021, 2021
Antiseizure Medication Withdrawal in Seizure-Free Patients: Practice Advisory Update Summary
Neurol 97:1072-1081, Gloss, D.,et al, 2021
Epilepsy in Older People
Lancet 395:735-748, Sen, A.,et al, 2020
Deprescribing in Epilepsy
JAMA Neurol 77:673-674, Terman, S.W.,et al, 2020
Choosing Anticonvulsant Medications to Manage Status Epilepticus
NEJM 382:2569-2572, Wu, K., 2020
FDA Approves Fenfluramine for Treatment of Seizures Associated with Dravet Syndrome
FDA June2020, , 2020
Efficacy and Safety of Adjunctive Lacosamide in the Treatment of Primary Generalised Tonic-Clonic Seizures: A Double-Blind, Randomised, Placebo-Controlled Trial
JNNP 91:1067-1075, Vossler, D.G.,et al, 2020
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Cannabidiol in Patients with Seizures Associated with Lennox-Gastaut Syndrome (GWPCARE4): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial
Lancet 391:1085-1096, Thiele, E.A.,et al, 2018
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome
NEJM 378:1888-1897, Devinsky, O.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy
Neurol 91:82-90, Kanner, A.M.,et al, 2018
Efficacy and Tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy
Neurol 91:74-81, Kanner, A.M.,et al, 2018
Antiepileptic Drug Treatment After An Unprovoked First Seizure
Neurol 91:e1429-e1439,684, Bao, E.L.,et al, 2018
Switching the Manufacturer of Antiepileptic Drugs is Associated with Higher Risk of Seizures: A Nationwide Study of Prescription Data in Germany
Ann Neurol 84:918-925, Lang, J.D.,et al, 2018